Literature DB >> 30642386

Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.

David S Lawrence1,2, Nabila Youssouf3,4, Síle F Molloy5, Alexandre Alanio6, Melanie Alufandika7, David R Boulware8,9, Timothée Boyer-Chammard6, Tao Chen10, Francoise Dromer6, Admire Hlupeni11, William Hope12, Mina C Hosseinipour13, Cecilia Kanyama13, Oliver Lortholary6, Angela Loyse5, David B Meya8, Mosepele Mosepele4,14, Conrad Muzoora8, Henry C Mwandumba7,10, Chiratidzo E Ndhlovu11, Louis Niessen10, Charlotte Schutz15, Katharine E Stott7,12, Duolao Wang10, David G Lalloo10, Graeme Meintjes15, Shabbar Jaffar10, Thomas S Harrison5, Joseph N Jarvis3,4.   

Abstract

Following publication of the original article [1], we have been notified that one of the author names was listed incorrectly. Both incorrect and correct author names are presented below. The original publication has been corrected.

Entities:  

Year:  2019        PMID： 30642386      PMCID： PMC6332521          DOI： 10.1186/s13063-018-3155-9

Source DB:  PubMed          Journal:  Trials        ISSN： 1745-6215            Impact factor:   2.279


Correction to: Trials (2018) 19:649 https://doi.org/10.1186/s13063-018-3026-4 Following publication of the original article [1], we have been notified that one of the author names was listed incorrectly. Both incorrect and correct author names are presented below. The original publication has been corrected. Originally published name: Sile L F Molloy Correct name: Sile F Molloy
  1 in total

1.  AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.

Authors:  David S Lawrence; Nabila Youssouf; Síle F Molloy; Alexandre Alanio; Melanie Alufandika; David R Boulware; Timothée Boyer-Chammard; Tao Chen; Francoise Dromer; Admire Hlupeni; William Hope; Mina C Hosseinipour; Cecilia Kanyama; Oliver Lortholary; Angela Loyse; David B Meya; Mosepele Mosepele; Conrad Muzoora; Henry C Mwandumba; Chiratidzo E Ndhlovu; Louis Niessen; Charlotte Schutz; Katharine E Stott; Duolao Wang; David G Lalloo; Graeme Meintjes; Shabbar Jaffar; Thomas S Harrison; Joseph N Jarvis
Journal:  Trials       Date:  2018-11-23       Impact factor: 2.279
  1 in total
  2 in total

Review 1.  New Insights Into Cryptococcus Spp. Biology and Cryptococcal Meningitis.

Authors:  Elvis Temfack; Timothée Boyer-Chammard; David Lawrence; Sarah Delliere; Angela Loyse; Fanny Lanternier; Alexandre Alanio; Olivier Lortholary
Journal:  Curr Neurol Neurosci Rep       Date:  2019-10-31       Impact factor: 5.081

2.  Short-term Mortality Outcomes of HIV-Associated Cryptococcal Meningitis in Antiretroviral Therapy-Naïve and -Experienced Patients in Sub-Saharan Africa.

Authors:  Newton Kalata; Jayne Ellis; Cecilia Kanyama; Charles Kuoanfank; Elvis Temfack; Sayoki Mfinanga; Sokoine Lesikari; Duncan Chanda; Shabir Lakhi; Tinashe Nyazika; Adrienne K Chan; Joep J van Oosterhout; Tao Chen; Mina C Hosseinipour; Olivier Lortholary; Duolao Wang; Shabbar Jaffar; Angela Loyse; Robert S Heyderman; Thomas S Harrison; Síle F Molloy
Journal:  Open Forum Infect Dis       Date:  2021-07-28       Impact factor: 4.423
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.